MARSHALL WACE, LLP - MARKER THERAPEUTICS INC ownership

MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 75 filers reported holding MARKER THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of MARKER THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$117,000
-59.5%
123,478
-27.7%
0.00%
-100.0%
Q3 2021$289,000
-68.4%
170,712
-47.9%
0.00%
-75.0%
Q2 2021$915,000
+127.0%
327,826
+134.5%
0.00%
+33.3%
Q4 2019$403,000
-51.2%
139,787
-13.4%
0.00%
-50.0%
Q3 2019$825,000161,4000.01%
Other shareholders
MARKER THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Aisling Capital Management LP 2,000,000$10,220,0005.33%
NEA Management Company, LLC 5,000,000$25,550,0002.12%
One68 Global Capital, LLC 30,000$153,0000.35%
Perceptive Advisors 2,000,000$10,220,0000.28%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$511,0000.18%
Quad Capital Management Advisors LLC 58,232$298,0000.15%
Riggs Asset Managment Co. Inc. 46,019$235,0000.12%
Baker Brothers Advisors 1,500,000$7,665,0000.05%
FNY Investment Advisers, LLC 32,058$163,0000.05%
WEDBUSH SECURITIES INC 56,568$289,0000.03%
View complete list of MARKER THERAPEUTICS INC shareholders